Showing results (21-30 of 372) with videos related to
Sort By:
Pageof 38
The EPMA Journal|June 29, 2012
Unlocking Pandora's box: personalising cancer cell death in non-small cell lung cancerDean A Fennell, Charles SwantonBMC Medicine|July 19, 2017
The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcomeDeborah R Caswell, Charles SwantonMolecular Oncology|August 5, 2014
Tumour heterogeneity and the evolution of polyclonal drug resistanceRebecca A Burrell, Charles SwantonCancer Discovery|August 3, 2017
The GENIE Is Out of the Bottle: Landmark Cancer Genomics Dataset ReleasedKevin Litchfield, Samra Turajlic, Charles SwantonCell Cycle (Georgetown, Tex.)|April 22, 2006
Chromosomal instability, colorectal cancer and taxane resistanceCharles Swanton, Ian Tomlinson, Julian DownwardAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Molecular profiling and the reclassification of cancer: divide and conquerJavier Munoz, Charles Swanton, Razelle KurzrockBiochemical Pharmacology|December 24, 2011
Tumour heterogeneity and drug resistance: personalising cancer medicine through functional genomicsAlvin J X Lee, Charles SwantonBritish Journal of Cancer|February 24, 2021
Understanding the impact of immune-mediated selection on lung cancer evolutionRachel Rosenthal, Charles Swanton, Nicholas McGranahanSeminars in Cancer Biology|February 25, 2021
Impact of cancer evolution on immune surveillance and checkpoint inhibitor responseYin Wu, Dhruva Biswas, Charles SwantonPageof 38